» Articles » PMID: 29350399

Biological Functions of Elabela, a Novel Endogenous Ligand of APJ Receptor

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2018 Jan 20
PMID 29350399
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The G protein-coupled receptor APJ and its cognate ligand, apelin, are widely expressed throughout human body. They are implicated in different key physiological processes such as angiogenesis, cardiovascular functions, fluid homeostasis, and energy metabolism regulation. Recently, a new endogenous peptidic ligand of APJ, named Elabela, has been identified and shown to play a crucial role in embryonic development. In addition, increasing evidences show that Elabela is also intimate associated with a large number of physiological processes in adulthood. However, a comprehensive summary of Elabela has not been reported to date. In this review, we provide an overview of the biological functions of Elabela. Collectively, Elabela, a potential therapeutic peptide, exerts diverse biological functions in both embryos and adult organisms, such as dysontogenesis, self-renewing of human embryonic stem cells, endoderm differentiation, heart morphogenesis, cardiac dyfunctions, blood pressure control, angiogenesis, blood pressure control, regulation of food and water intake, bone formation, and kidney diseases.

Citing Articles

ELABELA-APJ Axis Enhances Mesenchymal Stem Cell Proliferation and Migration via the METTL3/PI3K/AKT Pathway.

Xu D, Fu J, Liu X, Hong Y, Chen X, Li S Acta Naturae. 2024; 16(1):111-118.

PMID: 38698964 PMC: 11062101. DOI: 10.32607/actanaturae.17863.


Serum Elabela expression is decreased in hypertensive patients and could be associated with the progression of hypertensive renal damage.

Tian G, Zheng Q, Zhang Q, Liu X, Lu X Eur J Med Res. 2024; 29(1):94.

PMID: 38297369 PMC: 10832183. DOI: 10.1186/s40001-024-01674-1.


ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway.

Chen Z, Wang Z, Hu Y, Lin H, Yin L, Kong J Inflammation. 2023; 46(6):2343-2358.

PMID: 37540330 PMC: 10673989. DOI: 10.1007/s10753-023-01882-7.


APJ as Promising Therapeutic Target of Peptide Analogues in Myocardial Infarction- and Hypertension-Induced Heart Failure.

Rossin D, Vanni R, Lo Iacono M, Cristallini C, Giachino C, Rastaldo R Pharmaceutics. 2023; 15(5).

PMID: 37242650 PMC: 10223849. DOI: 10.3390/pharmaceutics15051408.


Sexual Dimorphism in the Polarization of Cardiac ILCs through Elabela.

Lopes Salles E, Naeini S, Bhandari B, Khodadadi H, Threlkeld E, Rezaee S Curr Issues Mol Biol. 2023; 45(1):223-232.

PMID: 36661503 PMC: 9856941. DOI: 10.3390/cimb45010017.